Parties d'ouvrages collectifs (4)
  1. 1. Argacha, J.-F., Adamopoulos, D., Dreyfuss, C., Berkenboom, G., & Van De Borne, P. (2011). Effect of cigarette smoke on oxidative stress and vascular endothelial function. In Oxidative Stress: A Focus on Cardiovascular Disease Pathogenesis (pp. 235-256). Nova Science Publishers, Inc.
  2. 2. Ciarka, A., Van De Borne, P., & Naeije, R. (2008). Focus on sympathetic nervous system activation in pulmonary arterial hypertension and after heart transplantation. In Heart failure and sympathetic nervous system. VDM Verlag Dr. Müller e.K.
  3. 3. Degaute, J.-P., & Van De Borne, P. (2001). Hypertension Artérielle et Cerveau. In R. Asmar, C. Hugue, & M. Safar (Eds.), Les Tableaux Cliniques de l’HTA et ses Retentissements, Therval Medical (pp. 91-96).
  4. 4. Van De Borne, P., & Degaute, J.-P. (1992). Monitorage non-invasif de la pression artérielle en Unité de Soins Intensifs. In G. Annat & F. Clergue (Eds.), Monitorage non-invasif en réanimation (pp. 3-10). Paris: Masson.(Collection d’Anesthésiologie et de Réanimation).
    5.   Articles dans des revues avec comité de lecture (232)
  5. 1. Gillet, A., Lamotte, M., Forton, K., Roussoulieres, A., Dewachter, C., Bouziotis, J., Deboeck, G., & Van De Borne, P. (2023). Hemodynamic Tolerance of New Resistance Training Methods in Patients With Heart Failure and Coronary Artery Disease: A RANDOMIZED CROSSOVER STUDY. Journal of Cardiopulmonary Rehabilitation and Prevention, 43(6), 453-459. doi:10.1097/HCR.0000000000000794
  6. 2. El Oumeiri, B. G., Dewachter, L., Van De Borne, P., Hubesch, G., Melot, C., Jespers, P., Stefanidis, C., McEntee, K., & Vanden Eynden, F. (2023). Altered Left Ventricular Rat Gene Expression Induced by the Myosin Activator Omecamtiv Mecarbil. Genes, 14(1). doi:10.3390/genes14010122
  7. 3. Balali, P., Rabineau, J., Hossein, A., Tordeur, C., Debeir, O., & Van De Borne, P. (2022). Investigating Cardiorespiratory Interaction Using Ballistocardiography and Seismocardiography—A Narrative Review. Sensors, 22(23), 9565. doi:10.3390/s22239565
  8. 4. Forton, K., Lamotte, M., Gillet, A., Chaumont, M., Van De Borne, P., & Faoro, V. (2022). Beta-Adrenergic Receptor Blockade Effects on Cardio-Pulmonary Exercise Testing in Healthy Young Adults: A Randomized, Placebo-Controlled Trial. Sports Medicine - Open, 8(1). doi:10.1186/s40798-022-00537-5
  9. 5. El Oumeiri, B. G., Van De Borne, P., Hubesch, G., Jespers, P., Dewachter, L., Stefanidis, C., McEntee, K., & Vanden Eynden, F. (2022). Detection of soluble suppression of tumorigenicity 2 and N-terminal B-type natriuretic peptide in a rat model of aortic regurgitation: differential responses to omecamtiv mecarbil. Journal of basic & clinical physiology & pharmacology, 33(6), 743-750. doi:10.1515/jbcpp-2022-0215
  10. 6. Lavis, P., Morra, S., Orte Cano, C., Albayrak, N., Corbiere, V., Olislagers, V., Dauby, N., Del Marmol, V., Marchant, A., Decaestecker, C., Mascart, F., De Vos, N., Van De Borne, P., Salmon, I., Remmelink, M., Parmentier, M., Cardozo, A. K., & Bondue, B. (2022). Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality. Frontiers in immunology, 13, 941663. doi:10.3389/fimmu.2022.941663
  11. 7. Douin, C., Forton, K., Lamotte, M., Gillet, A., & Van De Borne, P. (2022). Benefits of Cardio-Pulmonary Rehabilitation in Moderate to Severe Forms of COVID-19 Infection. Healthcare (Switzerland), 10(10), 2044. doi:10.3390/healthcare10102044
  12. 8. Gillet, A., Chaumont, M., Lamotte, M., Roussoulieres, A., Dewachter, C., Forton, K., Deboeck, G., & Van De Borne, P. (2022). EFFORT PERCEPTION AND HEMODYNAMIC RESPONSES TO THE 3/7 VS. 3X9 METHODS IN HEART FAILURE AND IN CORONARY ARTERY DISEASE PATIENTS: A RANDOMIZED-CROSS-OVER STUDY. Journal of hypertension, 40(Suppl 1), e295. doi:10.1097/01.hjh.0000838588.28000.dd
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Suivant >>